ajovy

Generic: fremanezumab-vfrm

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name ajovy
Generic Name fremanezumab-vfrm
Labeler teva pharmaceuticals usa, inc.
Dosage Form INJECTION
Routes
SUBCUTANEOUS
Active Ingredients

fremanezumab 225 mg/1.5mL

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 51759-202
Product ID 51759-202_fc78e33c-331e-42e0-b780-3db6f5c108bd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761089
Listing Expiration 2026-12-31
Marketing Start 2020-03-29

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51759202
Hyphenated Format 51759-202

Supplemental Identifiers

RxCUI
2056695 2056700 2287903 2287905
UNII
PF8K38CG54

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ajovy (source: ndc)
Generic Name fremanezumab-vfrm (source: ndc)
Application Number BLA761089 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 225 mg/1.5mL
source: ndc
Packaging
  • 1 CONTAINER in 1 CARTON (51759-202-10) / 1.5 mL in 1 CONTAINER
  • 1 CONTAINER in 1 CARTON (51759-202-11) / 1.5 mL in 1 CONTAINER
  • 3 CONTAINER in 1 CARTON (51759-202-22) / 1.5 mL in 1 CONTAINER
source: ndc

Packages (3)

Ingredients (1)

fremanezumab (225 mg/1.5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "fc78e33c-331e-42e0-b780-3db6f5c108bd", "openfda": {"unii": ["PF8K38CG54"], "rxcui": ["2056695", "2056700", "2287903", "2287905"], "spl_set_id": ["98e344ea-5916-4947-b6f2-4a76ccc04b6b"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CONTAINER in 1 CARTON (51759-202-10)  / 1.5 mL in 1 CONTAINER", "package_ndc": "51759-202-10", "marketing_start_date": "20200329"}, {"sample": true, "description": "1 CONTAINER in 1 CARTON (51759-202-11)  / 1.5 mL in 1 CONTAINER", "package_ndc": "51759-202-11", "marketing_start_date": "20200329"}, {"sample": false, "description": "3 CONTAINER in 1 CARTON (51759-202-22)  / 1.5 mL in 1 CONTAINER", "package_ndc": "51759-202-22", "marketing_start_date": "20200831"}], "brand_name": "AJOVY", "product_id": "51759-202_fc78e33c-331e-42e0-b780-3db6f5c108bd", "dosage_form": "INJECTION", "product_ndc": "51759-202", "generic_name": "fremanezumab-vfrm", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AJOVY", "active_ingredients": [{"name": "FREMANEZUMAB", "strength": "225 mg/1.5mL"}], "application_number": "BLA761089", "marketing_category": "BLA", "marketing_start_date": "20200329", "listing_expiration_date": "20261231"}